Simulations Plus Inc

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative 10.91 M19.2 M17.9 M21.86 M13.32 M18.13 M 22.61 M Flussi di cassa derivanti dalle attività di investimento -75.51 M-26.74 M4.3 M7.37 M-53.97 M3.56 M — Liquidità derivante dalle attività di finanziamento 102.37 M-4.68 M-7.62 M-23.27 M-6.57 M-1.15 M — Liquidità libera 8.33 M14.63 M13.93 M18.18 M9.56 M14.78 M 19.88 M

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

SLP

Financials

Simulations Plus Inc

Notizie

Simulations Plus: Down Substantially, Not An Automatic Buy (NASDAQ:SLP)

Simulations Plus Q2 Earnings & Revenues Beat, Jump Y/Y, Shares Soar

TD Cowen riduce il target di prezzo di Simulations Plus per timori fiscali

Wall Street oggi: 5 azioni calde da WD-40 a Lotus

Simulations Plus, Inc. (SLP) Q2 2026 Earnings Call Transcript

Simulations Plus, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SLP) 2026-04-09

Simulations Plus Q2 FY26: margini in espansione nonostante crescita contrastante

Simulations Plus supera le aspettative sugli utili del Q2 2026

Simulations Plus (SLP) Beats Q2 Earnings and Revenue Estimates

Le azioni di Simulations Plus volano del 9% dopo aver superato le stime del Q2

Gli EPS di Simulations Plus hanno battuto le aspettative per 0,04$, il fatturato supera le previsioni

Adobe Systems (ADBE) Q1 Earnings and Revenues Top Estimates